New data reaffirm safety and effectiveness of Boston’s Farapulse PFA platform in persistent AF...
A late-breaking presentation at the annual congress of the European Heart Rhythm Association (EHRA; 12–14 April 2026, Paris, France) has reaffirmed the safety and...
Analyses reveal why false positives persist in AI-equipped implantable cardiac monitors
Implicity has revealed new research presented at the annual congress of the European Heart Rhythm Association (EHRA; 12–14 April 2026, Paris, France) examining why...
J&J highlights favourable 12-month interim results on Varipulse platform at EHRA 2026
Johnson & Johnson (J&J) has announced favourable 12-month interim effectiveness and safety results from VARIPURE—the largest prospective post-market follow-up study evaluating first-time pulsed field ablation...
Protaryx Medical receives US FDA clearance for proprietary transseptal puncture device
Protaryx Medical has received 510(k) clearance from the US Food and Drug Administration (FDA) to market its proprietary transseptal puncture device.
According to the company,...
